热门资讯> 正文
2024-10-09 20:21
WW: 56% | WW shares are trading higher after the company on Tuesday announced the addition of compounded semaglutide into its offering.
HELE: 17% | Helen of Troy shares are trading higher after the company reported better-than-expected Q2 financial results.
CLSD: 69% | Clearside Biomedical Says ODYSSEY Phase 2b Trial Of CLS-AX (Axitinib Injectable Suspension) For Neovascular Age-related Macular Degeneration Achieved Both Its Primary And Secondary Outcomes